Tick-Borne Encephalitis Vaccine

Understanding Tick-Borne Encephalitis Vaccine

Tick-borne encephalitis (TBE) is a viral infectious disease that affects the central nervous system. It is transmitted by the bite of infected ticks, found commonly in forested areas of Europe and Asia. The global prevalence of TBE has been increasing, with travellers to these regions at risk, particularly during warmer months when ticks are most active.

Prevention

Prevention of TBE primarily involves vaccination. The Tick-Borne Encephalitis Vaccine, known as TicoVac, is used for this purpose. It requires a course of three doses for complete immunisation. The ideal vaccination schedule should be discussed with a healthcare provider, but it is recommended to start as early as possible before travel to risk areas.

Countries at Risk

TBE is most commonly found in parts of Europe and Asia, including Central and Eastern Europe, Scandinavia, and Russia. It is also prevalent in China and Japan. Find country-specific vaccine recommendations with Travel Health Pro.

Signs and Symptoms

TBE often starts with flu-like symptoms, including fever, headache, and muscle pain. In severe cases, it can progress to encephalitis, leading to symptoms such as confusion, seizures, and even paralysis.